Psilocybin study on belief and insight in healthy adults
Treatments studied
This study tests whether a single dose of psilocybin (a psychedelic compound) can help people update their beliefs and gain new insights. It's for healthy adults with some prior psychedelic experience, and it's a small pilot study at Brown University.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and fluent in English.
- You need to be in good physical and mental health, confirmed through a medical check-up and psychiatric screening.
- You must have used a classic psychedelic (like psilocybin, LSD, or ayahuasca) at least once in your life without bad reactions.
- You must agree to use highly effective birth control during the study.
- You must avoid recreational drugs, including cannabis, and certain medications during the study.
- You need to arrange two trusted adults (18+) to pick you up after the dosing session and stay with you as emergency contacts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if psilocybin, a substance found in certain mushrooms, can help people with various mental health symptoms that affect daily life. You would take a single dose in a supervised setting and be monitored for changes in your mood and well-being.
This Phase 1/2 study tests psilocybin to see how it affects brain signals and the “content” of thoughts while you are monitored during the study. Because participants must be generally healthy and mentally stable, it may be an option if you meet those safety and medication rules and are comfortable having your brain activity measured.
This trial tests whether a single dose of psilocybin (a psychedelic substance) can change self-awareness in healthy adults. It aims to understand how this substance affects the brain, which might lead to new mental health treatments.
This trial tests how the setting and context affect the experience of psilocybin, a psychedelic drug. It aims to understand how the environment influences the effects in healthy adults.
This study tests whether combining mindfulness training with a single dose of psilocybin (a psychedelic found in certain mushrooms) can help healthy adults. It aims to explore how these two approaches together might improve well-being.
This study tests how psilocybin, a psychedelic substance, affects the brain and body in healthy volunteers. It aims to find biological and mental changes that could help future therapies.
Hear when a new Phase I trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.